Cargando…
Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life
The term receptor reserve, first introduced and used in the traditional receptor theory, is an integrative measure of response-inducing ability of the interaction between an agonist and a receptor system (consisting of a receptor and its downstream signaling). The underlying phenomenon, i.e., stimul...
Autores principales: | Zsuga, Judit, Erdei, Tamas, Szabó, Katalin, Lampe, Nora, Papp, Csaba, Pinter, Akos, Szentmiklosi, Andras Jozsef, Juhasz, Bela, Szilvássy, Zoltán, Gesztelyi, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154002/ https://www.ncbi.nlm.nih.gov/pubmed/28534854 http://dx.doi.org/10.3390/molecules22050839 |
Ejemplares similares
-
FSCPX, a Chemical Widely Used as an Irreversible A(1) Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium
por: Erdei, Tamas, et al.
Publicado: (2018) -
Accuracy and Precision of the Receptorial Responsiveness Method (RRM) in the Quantification of A(1) Adenosine Receptor Agonists
por: Szabo, Adrienn Monika, et al.
Publicado: (2019) -
An Advanced in Silico Modelling of the Interaction between FSCPX, an Irreversible A(1) Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium
por: Szabo, Adrienn Monika, et al.
Publicado: (2019) -
The effect of adenosine deaminase inhibition on the A(1) adenosinergic and M(2) muscarinergic control of contractility in eu- and hyperthyroid guinea pig atria
por: Pak, Krisztian, et al.
Publicado: (2015) -
A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A(1) Adenosine Receptor Antagonist So Far
por: Viczjan, Gabor, et al.
Publicado: (2021)